Clinical Trial Update: Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating intravenous ketamine for obsessive-compulsive disorder across Phase 1 and Phase 2; the study was terminated with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Wayne Goodman MD | Conditions: Obsessive Compulsive Disorder | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-10-02